ORCL · Oracle Corp · Financials

On June 8, 2022, Oracle borrowed $15,700,000,000 under the Bridge Facility to finance the acquisition of Cerner, repay certain indebtedness of Cerner or its subsidiaries in connection with such acquisition, and to pay related fees and expenses. All amounts borrowed under the Bridge Credit Agreement will become due on March 7, 2023, unless the commitments and outstanding loans are terminated or prepaid (as applicable) earlier (i) either at the request of Oracle, (ii) by the lenders if an event of default occurs, or (iii) if a mandatory prepayment event occurs. Interest is based on either (i) a Term SOFR-based formula plus a margin of 100.0 basis points to 137.5 basis points, depending on the credit rating assigned to Oracle’s long-term senior unsecured debt, or (ii) a Base Rate formula plus a margin of 0.0 basis points to 37.5 basis points, depending on the same such credit rating, each as set forth in the Bridge Credit Agreement.

Issuer evidence: On June 8, 2022, Oracle Corporation, a Delaware corporation (“Oracle”), completed its acquisition of Cerner Corporation, a Delaware corporation (“Cerner”), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”), dated December 20, 2021, among Oracle, Cerner, OC Acquisition LLC, a Delaware limited liability company and wholly owned subsidiary of Oracle (“Parent”), and Cedar Acquisition Corporation, a Delaware corporation and wholly owned subsidiary of Parent (“Purchaser”).

Supporting evidence: As previously disclosed, on March 8, 2022, Oracle entered into a $15.7 billion delayed draw term loan credit agreement (the “Bridge Credit Agreement”), which provides for an unsecured $15.7 billion, 364-day term loan commitment (the “Bridge Facility”) to Oracle, subject to the satisfaction of certain customary conditions.

Supporting evidence: As previously disclosed, on March 8, 2022, Oracle entered into a $15.7 billion delayed draw term loan credit agreement (the “Bridge Credit Agreement”), which provides for an unsecured $15.7 billion, 364-day term loan commitment (the “Bridge Facility”) to Oracle, subject to the satisfaction of certain customary conditions.

On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: Oracle Corporation (“Oracle”)

Supporting evidence: On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: Oracle Corporation (“Oracle”)

Supporting evidence: On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025

Issuer evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Issuer evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”)

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: Oracle Corporation (“Oracle”)

Supporting evidence: On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Issuer evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”)

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Issuer evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”)

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Issuer evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”)

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: Oracle Corporation (“Oracle”)

Supporting evidence: On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Issuer evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”)

Supporting evidence: On April 1, 2020, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,500,000,000 aggregate principal amount of its 2.500% notes due 2025, $2,250,000,000 aggregate principal amount of its 2.800% notes due 2027, $3,250,000,000 aggregate principal amount of its 2.950% notes due 2030, $3,000,000,000 aggregate principal amount of its 3.600% notes due 2040, $4,500,000,000 aggregate principal amount of its 3.600% notes due 2050 and $3,500,000,000 aggregate principal amount of its 3.850% notes due 2060 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 30, 2020 among Oracle and BNY Mellon Capital Markets, LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: Oracle Corporation (“Oracle”)

Supporting evidence: On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: Oracle Corporation (“Oracle”)

Supporting evidence: On March 24, 2021, Oracle Corporation (“Oracle”) consummated the issuance and sale of $2,750,000,000 aggregate principal amount of its 1.650% Notes due 2026, $2,000,000,000 aggregate principal amount of its 2.300% Notes due 2028, $3,250,000,000 aggregate principal amount of its 2.875% Notes due 2031, $2,250,000,000 aggregate principal amount of its 3.650% Notes due 2041, $3,250,000,000 aggregate principal amount of its 3.950% Notes due 2051 and $1,500,000,000 aggregate principal amount of its 4.100% Notes due 2061 (collectively, the “Notes”), pursuant to an underwriting agreement dated March 22, 2021 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 27, 2024, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 aggregate principal amount of its 4.200% Notes due 2029, $1,750,000,000 aggregate principal amount of its 4.700% Notes due 2034, $1,750,000,000 aggregate principal amount of its 5.375% Notes due 2054 and $1,250,000,000 aggregate principal amount of its 5.500% Notes due 2064 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 25, 2024 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 27, 2024, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 aggregate principal amount of its 4.200% Notes due 2029, $1,750,000,000 aggregate principal amount of its 4.700% Notes due 2034, $1,750,000,000 aggregate principal amount of its 5.375% Notes due 2054 and $1,250,000,000 aggregate principal amount of its 5.500% Notes due 2064 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 25, 2024 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein.

Issuer evidence: On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Supporting evidence: On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein.

Issuer evidence: On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Supporting evidence: On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 27, 2024, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 aggregate principal amount of its 4.200% Notes due 2029, $1,750,000,000 aggregate principal amount of its 4.700% Notes due 2034, $1,750,000,000 aggregate principal amount of its 5.375% Notes due 2054 and $1,250,000,000 aggregate principal amount of its 5.500% Notes due 2064 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 25, 2024 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 27, 2024, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 aggregate principal amount of its 4.200% Notes due 2029, $1,750,000,000 aggregate principal amount of its 4.700% Notes due 2034, $1,750,000,000 aggregate principal amount of its 5.375% Notes due 2054 and $1,250,000,000 aggregate principal amount of its 5.500% Notes due 2064 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 25, 2024 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein.

Issuer evidence: On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Supporting evidence: On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 27, 2024, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 aggregate principal amount of its 4.200% Notes due 2029, $1,750,000,000 aggregate principal amount of its 4.700% Notes due 2034, $1,750,000,000 aggregate principal amount of its 5.375% Notes due 2054 and $1,250,000,000 aggregate principal amount of its 5.500% Notes due 2064 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 25, 2024 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 27, 2024, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 aggregate principal amount of its 4.200% Notes due 2029, $1,750,000,000 aggregate principal amount of its 4.700% Notes due 2034, $1,750,000,000 aggregate principal amount of its 5.375% Notes due 2054 and $1,250,000,000 aggregate principal amount of its 5.500% Notes due 2064 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 25, 2024 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 27, 2024, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 aggregate principal amount of its 4.200% Notes due 2029, $1,750,000,000 aggregate principal amount of its 4.700% Notes due 2034, $1,750,000,000 aggregate principal amount of its 5.375% Notes due 2054 and $1,250,000,000 aggregate principal amount of its 5.500% Notes due 2064 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 25, 2024 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 27, 2024, Oracle Corporation (“Oracle”) consummated the issuance and sale of $1,500,000,000 aggregate principal amount of its 4.200% Notes due 2029, $1,750,000,000 aggregate principal amount of its 4.700% Notes due 2034, $1,750,000,000 aggregate principal amount of its 5.375% Notes due 2054 and $1,250,000,000 aggregate principal amount of its 5.500% Notes due 2064 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 25, 2024 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein.

Issuer evidence: On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Supporting evidence: On February 6, 2023, Oracle Corporation (“Oracle”) consummated the issuance and sale of $750,000,000 aggregate principal amount of its 4.500% Notes due 2028, $750,000,000 aggregate principal amount of its 4.650% Notes due 2030, $1,500,000,000 aggregate principal amount of its 4.900% Notes due 2033 and $2,250,000,000 aggregate principal amount of its 5.550% Notes due 2053 (collectively, the “Notes”), pursuant to an underwriting agreement dated February 2, 2023 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On September 26, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $3,000,000,000 aggregate principal amount of its 4.450% Notes due 2030, $3,000,000,000 aggregate principal amount of its 4.800% Notes due 2032, $4,000,000,000 aggregate principal amount of its 5.200% Notes due 2035, $2,500,000,000 aggregate principal amount of its 5.875% Notes due 2045, $3,500,000,000 aggregate principal amount of its 5.950% Notes due 2055 and $2,000,000,000 aggregate principal amount of its 6.100% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated September 24, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.

Issuer evidence: On February 3, 2025, Oracle Corporation (“Oracle”) consummated the issuance and sale of $500,000,000 aggregate principal amount of its Floating Rate Notes due 2028, $1,500,000,000 aggregate principal amount of its 4.800% Notes due 2028, $1,250,000,000 aggregate principal amount of its 5.250% Notes due 2032, $1,750,000,000 aggregate principal amount of its 5.500% Notes due 2035, $1,750,000,000 aggregate principal amount of its 6.000% Notes due 2055 and $1,000,000,000 aggregate principal amount of its 6.125% Notes due 2065 (collectively, the “Notes”), pursuant to an underwriting agreement dated January 30, 2025 among Oracle and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the “Indenture”) among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the “First Supplemental Indenture”) among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers’ certificate issued pursuant thereto.